Dr. Arthur L. Eberly III, MD
Cardiology (Cardiovascular Disease Physician)
877 W Faris Rd, Ste B
Greenville, SC 29605
Who else practices at this address →
Greenville County is a federal mental health shortage area. About shortage areas
- Medicare participating
At a glance
- Medical school
- University of South Carolina School of Medicine (1989)
- Years since graduation
- 37
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 767
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1989Medical school: University of South Carolina School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Cardiovascular Disease Physician primary
SC license 18547
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Prisma Health Greenville Memorial Hospital Greenville, SC
- Prisma Health Greer Memorial Hospital Spartanburg, SC
- Prisma Health Hillcrest Hospital Simpsonville, SC
- Prisma Health Oconee Memorial Hospital Seneca, SC
- Prisma Health Baptist Easley Hospital Easley, SC
Medical groups
- Prisma Health University Medical Group (2,493 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 767
- Services billed
- 1,403
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 624 | 518 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 159 | 158 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 149 | 149 |
| New patient office or other outpatient visit, 45-59 minutes | 114 | 114 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 100 | 69 |
| Established patient office or other outpatient visit, 40-54 minutes | 64 | 59 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 49 | 37 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 36 | 36 |
| New patient office or other outpatient visit, 60-74 minutes | 34 | 34 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 28 | 28 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Metoprolol Succinate Other prescribers in Greenville, SC | 627 |
| Atorvastatin Calcium Other prescribers in Greenville, SC | 377 |
| Eliquis (apixaban) Other prescribers in Greenville, SC | 345 |
| Amlodipine Besylate Other prescribers in Greenville, SC | 263 |
| Spironolactone Other prescribers in Greenville, SC | 236 |
| Rosuvastatin Calcium Other prescribers in Greenville, SC | 229 |
| Losartan Potassium Other prescribers in Greenville, SC | 159 |
| Ezetimibe Other prescribers in Greenville, SC | 148 |
| Carvedilol Other prescribers in Greenville, SC | 125 |
| Entresto (sacubitril/valsartan) Other prescribers in Greenville, SC | 113 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 14 companies reported 54 payments worth $1,507 in total to this clinician.
| Amgen Inc. | $358 |
|---|---|
| Novartis Pharmaceuticals Corporation | $255 |
| Boston Scientific Corporation | $198 |
| Cvrx, Inc. | $177 |
| Philips North America LLC | $119 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $91.97 |
| Pfizer Inc. | $65.00 |
| E.r. Squibb & Sons, L.l.c. | $61.94 |
| Food and Beverage | $1,507 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $36,312 in research payments for these studies, mostly to the institutions running them.
- A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS)
Janssen Research & Development, LLC
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.